Financial News
Carl Zeiss Meditec said that it closed its financial year on a high note, consistently pursuing its growth course, with revenue increasing 12.1% in the fiscal year.
Iridex is among a group of companies which recently received letters from the SEC asking why they had not disclosed business dealings in Syria, Iran, Sudan, and Cuba, according to a report in the Financial Times.
PhotoMedex and Radiancy stockholders approved the merger of the two companies.
Synergetics USA saw growth in sales, gross margin, income from continuing operations, and net income in 1Q12 compared to 1Q11.

Other News
Bausch + Lomb Japan and Topcon Medical Japan will collaborate to co-promote their ophthalmic surgical products in Japan, including introduction of the Stellaris PC (Procedural Choice) vision enhancement system.
Biolase Technology is partnering with Seattle Study Club (SSC), a worldwide organization of dentists.
Carl Zeiss Meditec added new dry age-related macular degeneration (AMD) and new glaucoma diagnostic tools for its Cirrus HD-OCT. The FDA cleared the new Cirrus HD-OCT software version 6.0 on January 20, 2012.
Guided Therapeutics wants an independent panel review of its premarket approval (PMA) application for the LuViva advanced cervical scan after it received a not-approvable letter from the FDA. The company filed for a CE Mark in January 2012.
Iridex said that the results of a clinical study evaluating its MicroPulse laser therapy showed that the tissue sparing subvisible device is superior to anti-VEGF injections for patients with central serous chorioretinopathy (CSC).
LCA-Vision said that 14,205 procedures were performed during 4Q11, an increase of 30% vs. 10,891 procedures in 4Q10. Same-store procedures increased 33% from 10,671 procedures in 4Q10, the fifth consecutive quarter of year-to-year samestore procedure growth.
Maquet Cardiovascular is the new exclusive distributor of Novadaq’s CO2 Heart Laser systems and procedure kits in the US.
Palomar Medical’s PaloVia Skin Renewing Laser won the NewBeauty magazine most innovative at-home beauty device award in the magazine’s annual beauty awards.
Solta Medical’s Liposonix technology is now available in the US and Canada.
Spectranetics has an agreement with ThermopeutiX to commercialize the TAPAS catheter, a therapeutic infusion system. In other news, Spectranetics and Medtronic terminated their license agreement after a dispute over whether royalties were owed. As part of the agreement, Spectranetics will pay Medtronic $3 million.
Syneron Medical’s eLaser, eLight, eMatrix, eMax, and VelaShape systems are now available in China.
The FDA gave TearLab a CLIA waiver for its TearLab Osmolarity System.